The collaboration between the Universities of Cambridge and Manchester is one of four new imaging centres to get a major boost from a £35 million nationwide initiative to develop cutting edge imaging technologies for basic and clinical cancer research.
Cancer Research UK and the Engineering and Physical Sciences Research Council (EPSRC) are together committing £35 million for five years to four separate cancer imaging centres across the country, helping to cement the UK’s position as a world leader in cancer imaging research. The new initiative builds on the £50 million initial investment in October 2008.
This latest funding will bring together scientists, engineers and clinicians to develop new imaging techniques and applications which will help clinicians learn more about how tumours feed and grow, how cancer cells signal to one another, tumour blood supply, the environment surrounding tumours and molecular and genetic signatures.
The cancer imaging centres will serve as focal points of world-class research using a variety of techniques, such as optical microscopy, MRI (magnetic resonance imaging), functional MRI2, ultrasound, and PET (Positron Emission Tomography).
Dr Iain Foulkes, Cancer Research UK’s executive director of strategy and research funding, said: ‘Imaging is an invaluable tool in the fight against cancer. Being able to see what’s happening inside a patient is vitally important in understanding how treatments are working and the best ways to improve them.’
Professor David Delpy, chief executive of the EPSRC, said: ‘This large investment is great news and builds upon our previous successful collaboration with Cancer Research UK. These centres will bring together many of the UK’s leading scientists, engineers and clinicians interested in all aspects of imaging research, speeding up advances in new technologies and ensuring these are applied rapidly for the benefit of patients.’
The four imaging centres to receive funding are at: the University of Oxford, The Institute of Cancer Research, London, a joint imaging centre between King’s College London and University College London, and a new collaboration between the University of Cambridge and University of Manchester.
Imaging plays a crucial role in cancer management in three main ways; as an initial assessment of the extent of the cancer at the time of diagnosis, as a tool for guiding therapy and to assess patient response to therapy.
The cancer imaging centre in Cambridge and Manchester combines cutting-edge translational research and clinical trials with state-of-the-art imaging, genomics and pre-clinical research. By combining these two locations the cancer imaging centre has access to a large patient population and vital clinical trials infrastructure.
